Global and India Biobank Management Systems Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and India Biobank Management Systems Market Report & Forecast 2024-2034
Biobank Management System is a sample library resource management system based on cell sample workflow. According to the operations involved in the laboratory sample workflow, the entire process recording of the sample life cycle and efficient and continuous management of all-round quality control are achieved.
The global Biobank Management Systems revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India, the Biobank Management Systems revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
This report focuses on global and India Biobank Management Systems market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Biobank Management Systems will continue to grow rapidly in the future.
Global Biobank Management Systems Scope and Market Size
Biobank Management Systems market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biobank Management Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biobank Management Systems market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
Thermo Fisher Scientific
Agilent Technologies
Autoscribe Informatics
DiData
AgileBio
CloudLIMS
Modul-Bio
TD Biobank
OpenSpecimen
Information Management Services
Azenta
BBMS
LabKey
FreeLIMS
LabWare
Titian
Octalsoft
Interactive Software
eLabNext
SoftSystem
STARLIMS
NEST
Origincell
Improve Medical
Segment by Type
Cloud
On-Premises
Medical
Pharmaceutical
Laboratory
CRO
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Biobank Management Systems definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biobank Management Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biobank Management Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobank Management Systems revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
The global Biobank Management Systems revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India, the Biobank Management Systems revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
This report focuses on global and India Biobank Management Systems market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Biobank Management Systems will continue to grow rapidly in the future.
Global Biobank Management Systems Scope and Market Size
Biobank Management Systems market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biobank Management Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biobank Management Systems market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
By Company
Thermo Fisher Scientific
Agilent Technologies
Autoscribe Informatics
DiData
AgileBio
CloudLIMS
Modul-Bio
TD Biobank
OpenSpecimen
Information Management Services
Azenta
BBMS
LabKey
FreeLIMS
LabWare
Titian
Octalsoft
Interactive Software
eLabNext
SoftSystem
STARLIMS
NEST
Origincell
Improve Medical
Segment by Type
Cloud
On-Premises
Segment by Application
Medical
Pharmaceutical
Laboratory
CRO
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Biobank Management Systems definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biobank Management Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biobank Management Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobank Management Systems revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions